Skip to main content
. 2022 Jan 8;11(2):306. doi: 10.3390/jcm11020306

Table 5.

Pleural effusion in Mycoplasma pneumoniae pneumonia and interventional approach.

Category Total Population MrMP MLMP MSMP p-Value
Number of Subjects 5294 Number of Actual Responses 240 Number of Actual Responses 925 Number of Actual Responses 4129 Number of Actual Responses
Pleural effusion 402
(7.7)
5240 40 (16.7) 240 125 (13.5) 925 237
(5.8)
4075 <0.01
<1/4 of the thorax 290
(72.1)
30
(75.0)
99 (79.2) 161 (68.5) <0.01
1/4-1/2 of the thorax 5
(1.2)
2
(5.0)
0
(0)
3
(1.3)
≥1/2 of the thorax 2
(0.5)
1
(2.5)
1
(0.8)
0
(0)
Missing/unknown 105
(26.2)
7
(17.5)
25
(0.2)
73 (31.1)
Intervention
Thoracentesis 12
(0.2)
5240 4
(1.7)
240 4
(0.4)
925 4
(0.1)
4129 0.01
Chest tube insertion 39
(0.7)
5240 16
(6.7)
240 12
(1.3)
925 11
(0.3)
4129 <0.01

All data are presented as the number (%). For items with missing responses, the number of actual responses was entered in the column on the right. : The ratio was confirmed with the denominator of the patient group with pleural effusion and not the number of total respondents. Abbreviations: MrMP, macrolide-refractory M. pneumoniae pneumonia; MLMP, macrolide-less effective M. pneumoniae pneumonia; MSMP, macrolide-sensitive M. pneumoniae pneumonia.